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Abstract
It can be obtained from lichens biologically-active extracts and pure substances, 
many of them of phenolic nature. They are usually obtained by using organic solvents, 
such as diethyl ether. In this paper the usefulness of ether for the obtainment of 
crude extracts and the subsequent purification of pure substances from Brazilian 
lichen is reviewed, as well as alternatives to their production through cells or thallus 
immobilization in bioreactors and their entrapment in inert matrix.
ABBREVIATIONSASA: Acetylsalicylic Acid; ATR: Atranorin; BAR: Barbatic Acid; DIV: Divaricatic Acid; DYD: Dydimic Acid; FUM: Fumarprotocetraric Acid; LEC: Lecanoric Acid; NOR: Norstictic Acid; PRO: Protocetraric Acid; PUL: Pulvinic Acid; SAL: Salazinic Acid; STI: Stictic Acid; USN: Usnic Acid; VIC: Vicanicin; ZEO: Zeorin.
INTRODUCTION
An efficient extraction method and the adequate solvents 
are required to obtain bioactive compounds from plants and 
lichens. Organic solvents are indicated for extracting compounds 
with a different range of polarity, according to an eluotropic 
sequence, that indicates the more polar to apolar nature. In this 
context, lichens secondary metabolites are bioactive molecules, 
and due to their phenolic nature, their obtainment with organic 
solvents is feasible. Successive extractions in eluotropic series 
were achieved using n-hexane or petroleum ether, diethyl ether, 
acetone and methanol.
Lichens are symbiotic organisms formed by a fungus 
component, the mycobiont, and one or more green algae or 
cyanobacteria, the photobiont, forming a stable body, the 
thallus (Figure 1,2). The fungal partner comprises about 95% 
of the thallus and it is usually an ascomycete or less frequently 
a basidiomycete, whereas the photosynthetic partner is usually 
green algae or less frequently a cyanobacteria and comprises the 
remaining 5% of the thallus. They can be identified in various 
growth forms, being the most common: crustose, foliose, fruticose 
and dimorphic thalli (Figure 3-6). Despite of their slow growth 
and small sizes, some fruticose species are chosen for chemical 
and biotechnological assays [1-3].
Many lichen secondary metabolites originate from the 
fungal partners, but they are produced primarily in symbiotic 
association. When the mycobiont is isolated from its holobiont, 
phenolics are usually different from those produced in symbiosis. 
Mainly lichens produce unique secondary metabolites that 
are not produced by other fungi and plants, and that show 
some biological activities with interesting applications from a 
pharmacological point of view.
This way, there are many studies focusing on the biochemical 
and physiological activities associated with the lichen ether-
extracts or with the purified components or derivatives. 
From these data, our paper focuses on the description of the 
relationship between lichen compounds and ether, as a useful 
solvent for extraction and purification of biologically-active 
compounds from lichens, with emphasis to Brazilian species.
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hyphae surface in a crystal form. They are correlated to different 
functions, as allelopathic [6,7], antimicrobial [8], mucolytic [9], 
antitumor [10], molluscicide [11,12], teratogenic [13], etc.
Those substances are phenolic derivatives, grouped in four 
well differentiated structural groups: depsides, depsidones, 
dibenzofurans (including usnic acid - USN) and depsones. They 
are named as lichen substances or lichen acids [14], and formed 
by two or three phenolics units, originated from poliketonic 
carboxylic acids, derived from acetic acid. However, species 
whose photobiont is a cyanobacterium do not produce phenolic 
derivatives [15].Many molecular structures of lichen substances and 
biosynthetic pathways were described by Asahina and Shibata 
Figure 1 Thallus organization. A homoiomerous thallus (Leptogium 
sp.), showing upper cortex (uc), and photobiotic (p) and fungal hyphae 
(h) partners mixed internally. 
Figure 2 Thallus organization. A heteromerous thallus (Physcia sp.) 
with upper (uc) and lower (lc) cortices, and internally divided in algal 
layer (al), with its photobiont, and medulla (m), without photobiont. 
We can see a rhizine (r) from the inferior cortex for attachment to the substrate. 
Figure 3 Lichens growth forms. Crustose lichen (Herpothallon 
rubrocinctum).
Figure 4 Lichens growth forms. Foliose lichen (Parmotremapraesore-
diosum). 
Figure 5 Lichens growth forms. Fruticose lichen (Usnea sp.). 
Figure 6 Lichens growth forms. Dimorphic lichen (Cladonia sp.).
METABOLIC PATHWAYS
The primary metabolites of lichens are intracellular, as 
proteins, amino acids, polyols, carotenoids, polysaccharides and 
vitamins, usually found in the protoplast, often water soluble 
[4,5]. Products from secondary metabolism are water insoluble, 
have low molecular weight and are accumulated in the cortex or 
in the medulla. All of them are found extracellularly and/or on the 
Central
Bringing Excellence in Open Access


Pereira et al. (2017)
Email:  
J Drug Des Res 4(6): 1057 (2017) 3/6
[16], who divided them in aliphatic (fatty acids, polyols, and 
triterpenes) and aromatic (derivatives of tetralonic and 
pulvinic acid - PUL, depsides, depsidones, dibenzofurans 
and diketopiperazin derivatives). Nowadays, the more used 
classification system is that proposed by Culberson and Elix 
[17], in which the substances are ordered according to their 
biosynthetic origin, those derived from acetate-polymalonate, 
from shikimic or from mevalonic acids pathways, according to 
Table 1 [18].
USEFULNESS OF ETHER AS AN EXTRACTOR OF 
LICHEN BIOLOGICALLY-ACTIVE COMPOUNDS
Biological assays with plants and lichens usually require a 
previous screening by using crude extracts, to verify the presence 
of any bioactive substance in those preparations. Several lichen 
secondary metabolites, with recognized pharmacological and 
biological potentials [12,19], such as USN, barbatic acid (BAR) 
and atranorin (ATR), are extracted by processes that include 
ether [10].
The selective extraction with organic solvents, considering 
the polarity of target molecules, is so remarkable in the process to obtain bioactive compounds.
In the case of lichens, one may find water soluble active 
substances, and/or lipophilic compounds with phenolic 
structure. The extraction with ether of thalli of several species 
allow to obtaining compounds with remarkable activity and/or 
with industrial interest, such as USN. The ether extract of some 
species, such as Cladonia substellata, precedes the purification 
of this acid, as well as the first step to obtain its water soluble 
salt (usnate), also bioactive [11]. In other cases, the ether 
extracts from C. substellata, Cladonia crispatula, and Cladina 
dendroides, are active against four lines of cancer cells, inhibiting 
their proliferation, with remarkable action of ether extract of C. substellata and C. dendroides, using adriamicin and taxol 
as reference products [20]. Testing in vivo ether extract of C. 
verticillaris, or a combined extraction with ether and ethyl acetate, 
against solid tumors (Ehrlich carcinoma and Sarcoma-180), they 
were able to inhibit tumor development. Extracts were active 
mainly from samples collected in the dry season, probably by the 
retention of the bioactive compounds, fumarprotocetraric (FUM) 
and protocetraric (PRO) acids, due to low rain occurrence [21].
Some studies demonstrated that ether extract is as active 
as the pure compound, even more active in some cases. For 
example, Martins et al. [8], reported the antimicrobial activity of BAR from Cladia aggregata and its ether extract, but also 
suggested through biochromatography any interaction of this 
acid with some other compounds of the extract. This was also 
Figure 7 Crystal and chemical structures of some bioactive lichen substances isolated from Brazilian species. (A) BAR; (B) USN; (C) DIV; (D) Calicin.
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detected for Heterodermia leucomela, an ATR rich lichen species, 
whose extract also contains zeorin (ZEO) and USN [22]. Ramalina 
sorediosa, whose ether extract contains salazinic acid (SAL) and 
USN, exhibited antibiotic action against B. subtilis and S. aureus, 
and a synergism was also reported [23]. Ribeiro et al. [24], 
also reported action of ether extract from C. substellata against 
human and plant pathogenic bacteria. The authors considered 
the extract more active against plant pathogens and supposed 
a synergic action of USN with norstictic acid (NOR). The same 
extract and substance were tested against Staphylococcus spp. 
obtained from skin and ears of dogs and cats with suspicion of 
pyoderma and otitis, being considered these products as effective 
for the treatment of these diseases [25].
In addition to antimicrobial action, antinociceptive activity 
of ether extract and ATR isolated from Cladina dendroides was 
achieved through induction of acetic acid and writhing test in mice. 
The presence of atranorin ATR and FUM in the extract provided 
a remarkable action, higher than acetylsalicylic acid (ASA), low 
toxicity, and a probable synergism between both compounds 
[26]. On the other hand, ether extract from Teloschistes flavicans, 
rich in vicanicin (VIC) (60.26%), inhibited paw edema in mice at 
120 and 180 min of treatment, and no granuloma or acute toxic 
symptoms were observed [27].Potassium usnate and BAR from C. substellata and C. 
aggregata, respectively, exhibited molluscicide action against 
schistosomiases vector. Ether extract of this last lichen species 
also exhibited synergism, probably due to the occurrence of 
stictic acid (STI) in the mixture [11,12].
Complementary studies focusing on the action of lichen 
substances in the organisms have been developing, as teratogenic 
ability of those drugs on organogenesis. USN isolated from ether 
extract of C. substellata caused reduction of weight in pregnant 
rats, increase of resorption, decrease of viable fetuses, besides 
morphological changes as exposure of eyes, atrophy of limbs and 
histological injuries [13].
Assays with crude extracts, sometimes, reveal promissory 
results, as those found with pure compounds, and studies 
focusing on side effects, toxicity and other injuries caused by 
drugs, are important for completing the knowledge about natural 
products. In other hand, new biotechnological approaches have been optimized the action of these lichen substances by using 
nanotechnology for diminishing their toxicity by encapsulation 
using nanoparticles or microspheres [28], or through electrospun 
fibers, leading a controlled liberation of the substance into the 
organism [29].
PERSPECTIVE OF SUSTAINABLE USE OF LICHEN 
PRODUCTS
Since lichen compounds show several properties adequate 
for use in laboratory, at industrial or semi-industrial level, the 
eradication and extinction of species is a problem for observing 
and be caution, since lichen grow slowly, and their reposition 
to the environment can be impossible in some cases [30]. 
Procedures employing high biomass amounts, such as those 
used in the perfume industry, must be avoided. The responsible 
collection is mandatory, since several tons of lichens are extracted 
for cosmetic and natural medicine industries [31,32].
In this context, biotechnological methods are the alternative 
for a sustainable use of lichen biomass. Among some techniques, 
the immobilization of cell or thallus fragments in different kind of 
bioreactors, using inert matrices for entrapment, demonstrated 
to be a promissory technique to obtain active compounds 
[33,34]. Two kinds of matrices are commonly used. Devitalizing 
matrices, such as polyacrylamide, are preferently indicated to 
immobilize enzymes, such as orsellinate depside hydrolase [35] 
or depsidone ether hydrolase [36], whereas those that preserve 
cell vitality, such as polyhydroxyurethane, calcium alginate 
or kaolinite, are preferred to cell or tissues immobilization. 
Polyhidroxyurethane immobilizes cells by adhesion in such a 
way that immobilizates are instable [30]. Calcium alginate shows 
to be a good matrix for cell immobilization although precursors 
containing monovalent cations, such as Na+ or K+ must be avoided 
in order to impede calcium replacement and the disaggregation 
of the immobilizate [37]. For long periods of bioreactors activity, 
the use of some antibiotics is required to impede that phenolics 
produced by the immobilizates could be catabolized by epiphytic 
bacteria accompanying lichen fragments [38]. Incubation of 
immobilizates with the phenolic precursors will be in statics 
(without stirring) or shaking conditions, being this last the most 
efficient procedure since the limit later around the immobilizates 
supports a resistance to the access of the precursors to the lichen 
cells and increases their efficiency. 
To produce lichen phenolics in bioreactors, immobilized 
cells or tissues were mixed with aqueous solutions of a 
precursor (sodium acetate). For extracting mid-polarity phenolic 
compounds from the cell washes, a mixture of diethyl ether and 
ethyl acetate (65:35, v/v) is required [39]. In these extracts, it 
was possible to detect USN [39,34], didymic acid (DYD), [40], 
BAR [41] PRO, FUM [42] and lecanoric acid (LEC) [43] acids 
as well as ATR [44], all of them bioactive compounds. Even 
immobilization techniques can be used to elucidate unknown 
enzymatic mechanisms of lichen phenolics production, such as 
cofactor requirements to produce FUM from its precursor, PRO 
[45].
CONCLUSION
From the properties and viability of ether use for obtainment 
of bioactive compounds from lichens, the indicative of this solvent 
for preceding biological assays, or for cosmetic preparations is feasible.
Besides the extraction and purification of compounds in 
laboratory or industrial/semi industrial scales, the techniques 
of immobilization of cell or thallus fragment can preserve the 
natural resources and the environment where lichen occur, 
indicating a sustainable use of these organisms. More promissory 
results can be found in the next studies with lichens and their 
ether preparations.
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